20
Aurobindo Pharma Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Aripiprazole, Process II, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2018-134 - Rev 02
This Chemical Type CEP, issued on July 01, 2021, remains in force until June 09, 2023, ensuring its reliability within the pharmaceutical industry.
Substance Number 2617 associated with this CEP further emphasizes